Entropy Neurodynamics Limited has released a press release.
PLEXOVAL Exosome Wound Healing Human Study Starts
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Share Purchase Plan 2019 Offer Document
- Share Placement and Share Purchase Plan Announced
- Securures Ethics Approval for Plexoval Clinical Trial
- Market Update
- Explainer The critical bottleneck of exosome isolation
Later from Entropy Neurodynamics
- Appendix 4E and Annual Financial Report FY 2019
- Appendix 4C - quarterly
- Appointment of Chief Commercial Officer
- Development Program Update
- Key Management Contracts Extended
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics